Itau Unibanco Holding S.A. Biogen Inc. Transaction History

Itau Unibanco Holding S.A.

$2.95 Billion
Q3 2024

A detailed history of Itau Unibanco Holding S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 231 shares of BIIB stock, worth $36,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

231

Previous 141 63.83%

Holding current value

$36,426

Previous $32,000 37.5%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $17,016 - $21,312	90 Added 63.83%	231 $44,000
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $26,863 - $33,377	141 New	141 $32,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $13,132 - $15,808	59 Added 28.23%	268 $69,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $253 - $285	-1 Reduced 0.48%	209 $53,000
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $275 - $318	-1 Reduced 0.47%	210 $59,000
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $1,767 - $2,147	-7 Reduced 3.21%	211 $58,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $21,221 - $29,262	-109 Reduced 33.33%	218 $58,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $562 - $669	-3 Reduced 0.91%	327 $67,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $581 - $732	3 Added 0.92%	330 $69,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $23,511 - $30,215	105 Added 47.3%	327 $78,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $21,790 - $28,416	77 Added 53.1%	222 $63,000
Q2 2021 Aug 17, 2021	BUY	$259.0 - $414.71 $37,555 - $60,132	145 New	145 $50,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $72,424 - $95,914	-280 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $138,188 - $175,294	-514 Reduced 64.74%	280 $89,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $174,727 - $241,431	794 New	794 $236,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $405,743 - $455,080	-1,866 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $280,691 - $309,401	1,280 Added 218.43%	1,866 $436,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $47,902 - $60,673	-172 Reduced 22.69%	586 $171,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $248,309 - $324,720	-846 Reduced 52.74%	758 $268,000
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $719,768 - $857,813	-2,795 Reduced 63.54%	1,604 $466,000
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $382,391 - $540,827	1,470 Added 50.19%	4,399 $1.21 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $36,916 - $41,349	120 Added 4.27%	2,929 $933,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $789,750 - $926,099	2,809	2,809 $2.78 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Account

Itau Unibanco Holding S.A. Biogen Inc. Transaction History